However, the role of the AKT/mTOR/STAT3/ID1 axis in liver cancer remains unexplored, and the effects of therapeutics targeting the AKT/mTOR/STAT3/ID1 signaling pathway remain unknown. Here, STAT3 is linked to liver cancer.